Johnson & Johnson to Participate in the Cowen 42nd Annual Health Care Virtual Conference
Rhea-AI Summary
Johnson & Johnson (NYSE: JNJ) will participate in the Cowen 42nd Annual Health Care Virtual Conference on March 7, 2022, at 9:10 a.m. (Eastern Time). Mathai Mammen, Executive VP of Pharmaceuticals R&D, will represent the company. Investors and interested parties can access the conference call via the Johnson & Johnson website. A webcast and podcast replay will be available approximately 48 hours after the live event.
Positive
- None.
Negative
- None.
News Market Reaction – JNJ
In the trading session that priced this news, JNJ gained 0.26%, reflecting a mild positive market reaction.
Data tracked by StockTitan Argus on the day of publication.
AI-generated analysis. How Rhea-AI works. Not financial advice.
NEW BRUNSWICK, N.J., Feb. 7, 2022 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ) will participate in the Cowen 42nd Annual Health Care Virtual Conference on Monday, March 7th. Mathai Mammen, Executive Vice President, Pharmaceuticals R&D will represent the Company in a session scheduled at 9:10 a.m. (Eastern Time).
This conference call will be available to investors and other interested parties by visit the Johnson & Johnson website at www.investor.jnj.com.
A webcast and podcast replay will be available approximately 48 hours after the live webcast.
View original content to download multimedia:https://www.prnewswire.com/news-releases/johnson--johnson-to-participate-in-the-cowen-42nd-annual-health-care-virtual-conference-301476930.html
SOURCE Johnson & Johnson
